CL
CRDF icon

CSS LLC’s Cardiff Oncology CRDF Stock Holding History

CSS LLC’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-35,920
Closed -$55K – 981
2022
Q3 		$55K Buy
35,920
+3,926
+12% +$9.45K ﹤0.01% 876
2022
Q2 		$70K Hold
31,994
– – ﹤0.01% 920
2022
Q1 		$79K Buy
31,994
+15,800
+98% +$55.9K ﹤0.01% 962
2021
Q4 		$97K Hold
16,194
– – ﹤0.01% 1023
2021
Q3 		$108K Sell
16,194
-17,519
-52% -$110K ﹤0.01% 967
2021
Q2 		$224K Buy
+33,713
New +$286K 0.01% 826
2021
Q1 		– Sell
-8,955
Closed -$161K – 952
2020
Q4 		$161K Buy
+8,955
New +$157K 0.01% 660

Other funds holding CRDF

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return